SCTIMST Launches Chitra Core: A New Era in Coronary Stents
SCTIMST introduces Chitra Core, its inaugural coronary stent, promising advancements in cardiac care.
The Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) has announced the launch of Chitra Core, its first-ever coronary stent. This significant development marks SCTIMST's entry into the competitive field of cardiovascular medical devices, aiming to enhance treatment options for patients with coronary artery disease.
Innovative Design and Development
Chitra Core has been designed to meet the rigorous demands of coronary interventions. Developed by the Biomedical Technology Wing of SCTIMST, the stent promises improved flexibility and strength, characteristics crucial for navigating complex arterial blockages. The institute's researchers have focused on creating a device that not only meets international standards but also caters to the specific needs of the Indian healthcare landscape.
The stent is crafted from a cobalt-chromium alloy, known for its durability and biocompatibility. This material choice ensures that the stent can withstand the physiological demands placed upon it while minimizing adverse reactions within the body.
Addressing Healthcare Challenges
India faces a significant burden of cardiovascular diseases, with coronary artery disease being a leading cause of mortality. The introduction of Chitra Core is aimed at addressing this challenge by providing a cost-effective and reliable treatment option. By manufacturing the stent domestically, SCTIMST hopes to reduce dependency on imported medical devices, thereby lowering treatment costs for patients.
Dr. Asha Kishore, Director of SCTIMST, emphasized the importance of this launch, stating that Chitra Core represents a major step forward in the institute's mission to innovate and improve healthcare delivery in India. The stent's development aligns with the government's 'Make in India' initiative, promoting self-reliance in the medical technology sector.
Regulatory Approvals and Future Prospects
The Chitra Core stent has successfully undergone rigorous testing and received necessary regulatory approvals, ensuring its safety and efficacy. SCTIMST is now focusing on scaling up production to meet anticipated demand and exploring opportunities for international collaborations and exports.
As the institute prepares for a broader rollout, it plans to conduct further clinical trials and collect longitudinal data to continuously assess the stent's performance. These efforts will be critical in establishing Chitra Core as a preferred choice among healthcare providers.
With the launch of Chitra Core, SCTIMST has not only broadened its portfolio but also contributed to the global conversation on affordable and accessible cardiac care. The stent's introduction is poised to make a significant impact on the treatment landscape, offering hope to millions of patients.